Higgins, K. A., Hu, C., Ross, H. J., Jabbour, S. K., Kozono, D. E., Owonikoko, T. K., … Bradley, J. D. (2026). Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01569

Higgins, Kristin A., Chen Hu, Helen J. Ross, Salma K. Jabbour, David E. Kozono, Taofeek K. Owonikoko, Timothy A. Ritter, et al. “Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.” Journal of Clinical Oncology, January 13, 2026. https://doi.org/10.1200/jco-25-01569.

Higgins KA, Hu C, Ross HJ, Jabbour SK, Kozono DE, Owonikoko TK, et al. Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005. Journal of Clinical Oncology. 2026 Jan 13;

Higgins, Kristin A., et al. “Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.” Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Jan. 2026. Crossref, doi:10.1200/jco-25-01569.

Higgins KA, Hu C, Ross HJ, Jabbour SK, Kozono DE, Owonikoko TK, Ritter TA, Williams TM, Welsh J, Simko JP, Movsas B, Xiao C, Kaira K, Gupta AK, Mohindra P, Dib EG, Brownstein J, Chun S, Kuzma CS, Kotecha R, Onitilo AA, Chen Y, Stinchcombe TE, Wang X, Paulus R, Bradley JD. Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2026 Jan 13;